CJC1295,Ipamorelin 10/10 (Blend)*10vials

260.00
This combination is used for the synergistic regulation mechanism of the growth hormone axis. CJC-1295 prolongs the duration of endogenous growth hormone release signals, while Ipamorelin selectively stimulates growth hormone secretion. Mechanistically complementary, they act at distinct regulatory levels. Their combined use facilitates investigation of growth hormone secretion rhythms, feedback regulation, and endocrine system synergistic mechanisms. This combination holds significant experimental value for research into endocrine regulation and the growth axis.
 
The peptide will be provided as lyophilized powder to ensure maximum stability.
        SPECIAL OFFER

          Please select all product options

          Product was out of stock

          share
          Description

          ▎CJC1295 no DAC


          As a synthetic growth hormone-releasing hormone (GHRH) analog, the core mechanism of action of CJC1295 no DAC lies in its ability to significantly promote the endogenous secretion of growth hormone. By specifically binding to the corresponding receptor, this compound can not only effectively induce the pulsatile release of growth hormone, thus having a positive impact on the growth and repair process of muscle tissue, but also play a two-way regulatory role in the catabolism and anabolism of adipose tissue by regulating the energy metabolism pathway. At the same time, it can maintain and increase bone density by enhancing the activity of osteoblasts and inhibiting the function of osteoclasts.


          From the perspective of basic research and clinical application, these multiple biological effects make CJC1295 no DAC an important tool in the in-depth analysis of the growth hormone secretion mechanism. Especially in the field of diagnosis and treatment of growth hormone-related diseases, for endocrine disorders such as growth hormone deficiency and childhood short stature, its characteristic of promoting hormone secretion provides an experimental basis for exploring new treatment strategies. It is worth noting that for a series of aging-related phenotypes caused by the physiological decline of growth hormone with age, including decreased skeletal muscle mass, increased body fat percentage, and decreased skin elasticity, CJC1295 no DAC shows potential anti-aging biological effects by increasing the level of growth hormone in the circulatory system. This provides a new research direction for the intervention research of aging-related diseases and the application exploration of improving the quality of life of the elderly population.


          In the fields of exercise physiology and sports science, this compound has a positive effect on the muscle growth, post-exercise recovery, and improvement of athletic performance of athletes through multiple pathways such as accelerating muscle protein synthesis, promoting muscle fiber repair, and enhancing energy metabolism efficiency. Thus, it has become an important focus in the research of strategies for enhancing athletic ability in the field of sports medicine. Overall, with its unique mechanism of action and extensive biological effects, CJC1295 no DAC shows important research value and application potential in multiple fields such as basic medical research, clinical disease treatment, and sports science.


          ▎Ipamorelin


          Ipamorelin is a synthetic pentapeptide compound. As an important member of the growth hormone secretagogue family, its molecular structure design endows it with the ability to precisely regulate the growth hormone secretion axis. This compound binds with high affinity to the growth hormone secretagogue receptor (GHS-R), activating the downstream signaling pathway, thus efficiently inducing the pulsatile release of growth hormone (GH) and simultaneously promoting the gene expression and protein synthesis of insulin-like growth factor-1 (IGF-1). This dual mechanism of action not only regulates the energy metabolism process (including promoting amino acid uptake, accelerating protein synthesis, and optimizing fat catabolism), but also plays a positive regulatory role in tissue repair and growth by enhancing the cell proliferation signal.


          In clinical application research, Ipamorelin has shown multi-system regulatory effects: its effect on improving gastrointestinal motility is manifested as accelerating gastric emptying rate. Especially in the pathological state of postoperative ileus, it can effectively relieve intestinal motility disorders by promoting the peristaltic frequency and contraction intensity of gastrointestinal smooth muscles; in the field of pain management, this compound regulates nociceptive signal transmission through both central and peripheral pathways, showing a significant relieving effect on non-inflammatory visceral pain and somatic pain. Its mechanism of action may involve the activation of the endogenous opioid peptide system and the regulation of ion channel activity.


          Compared with traditional growth hormone secretagogues, the significant advantage of Ipamorelin lies in its high selectivity for growth hormone release - while effectively stimulating GH secretion, it has no significant effect on the secretion of other pituitary-adrenal axis hormones such as adrenocorticotropic hormone (ACTH) and cortisol, thus reducing the risk of adverse reactions caused by hormonal disorders. This pharmacological property gives it the potential for precise intervention in the replacement treatment of growth hormone deficiency, and at the same time provides a new drug target for the research on the pathogenesis of gastrointestinal motility disorders and the optimization of pain diagnosis and treatment programs. Currently, based on its unique mechanism of action and safety characteristics, the translational application research of Ipamorelin in the fields of endocrine diseases, digestive system diseases, and pain medicine is continuously deepening, showing broad clinical application prospects.


          ▎Summary


          Promoting Muscle Growth and Repair:

          The combined use of CJC1295 No DAC and Ipamorelin can significantly increase the synthesis of muscle proteins and accelerate the repair and regeneration of muscle tissue. Its mechanism of action may involve the direct stimulation of muscle cells by growth hormone, as well as the indirect promotion of muscle growth by regulating other growth factors and metabolic pathways. In the field of sports medicine, the combined application of these two peptide substances has important value. For fitness enthusiasts, it can promote muscle recovery after exercise, enhance muscle strength and volume, and improve training effects. Studies have shown that growth hormone can activate muscle stem cells, promoting their proliferation and differentiation into mature muscle cells, thus accelerating the muscle repair process.


          Optimizing Fat Metabolism:

          The combined use of Ipamorelin and CJC1295 No DAC can increase the level of growth hormone, thereby promoting the decomposition and oxidation of fat. Growth hormone can increase the activity of lipolytic enzymes in fat cells, promoting the decomposition of fat into free fatty acids and glycerol to provide energy for the body. At the same time, it can also improve the utilization efficiency of fat, reduce the storage of body fat, and improve body composition. This is of great significance for fat loss and body shaping, especially for those who want to reduce their body fat percentage and improve their body lines.


          Enhancing Energy Levels and Athletic Performance:

          The increase in growth hormone can increase the basal metabolic rate and enhance the efficiency of energy production and utilization. An increase in the basal metabolic rate means that the body can consume more energy even at rest, which helps to maintain the body's energy balance. This enables users to obtain higher energy levels during daily activities and exercise, extend exercise endurance, and improve athletic performance.


          Improving Sleep Quality:

          Growth hormone plays an important role in regulating the sleep cycle and quality. The combined use of Ipamorelin and CJC1295 No DAC can improve the sleep structure and increase the deep sleep time. Deep sleep is crucial for the body's recovery and repair. It can promote the secretion of growth hormone, enhance the function of the immune system, and improve the cognitive ability of the brain.


          Enhancing Immune Function:

          Growth hormone supports the normal function of the immune system. It can enhance the activity and function of immune cells, improve the body's immunity, and help resist diseases. By increasing the level of growth hormone, the combined use of Ipamorelin and CJC1295 No DAC can enhance the proliferation and differentiation ability of immune cells, promote the production of antibodies, and improve the body's resistance to pathogens.


          2. Application Fields


          Anti-aging Medicine:

          With the increase of age, the level of growth hormone in the human body gradually decreases, leading to aging phenomena such as muscle loss, fat gain, and skin relaxation. The combined use of Ipamorelin and CJC1295 No DAC can increase the level of growth hormone and has potential anti-aging effects. Researchers are exploring the application of these two peptide substances in delaying aging and improving the quality of life of the elderly. For example, they can be used to prevent and treat aging-related diseases such as senile muscle atrophy, osteoporosis, and cardiovascular diseases.


          Sports Medicine:

          In the sports field, the combined use of CJC1295 No DAC and Ipamorelin can promote muscle growth and repair, enhance athletic performance, and reduce the occurrence of sports injuries. Fitness enthusiasts can use these two peptide substances as an auxiliary means to improve training effects and accelerate the recovery process.


          Treatment of Endocrine Diseases:

          For endocrine diseases such as growth hormone deficiency and idiopathic short stature, the combined use of Ipamorelin and CJC1295 No DAC provides new ideas and methods for treatment. By regulating the secretion of growth hormone, it helps to improve the symptoms of patients and promote the normal development and growth of the body.


          About The Author

          The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.


          ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  


          The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.